Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer
Supitcha Kamolratanakul, Punnee Pitisuttithum
Vaccines (2021) Vol. 9, Iss. 12, pp. 1413-1413
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Human papillomavirus vaccination and cervical cancer risk
Lisa Rahangdale, Chemtai Mungo, Siobhán O’Connor, et al.
BMJ (2022), pp. e070115-e070115
Open Access | Times Cited: 93
Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics
Jonas Michel Wolf, Lucas Felipe Kist, Samanta Brangel Pereira, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 3
Open Access | Times Cited: 24
Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State
Ayazhan Akhatova, Azliyati Azizan, Kuralay Atageldiyeva, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1912-1912
Open Access | Times Cited: 43
Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?
Giovanna Milano, Giovanni Guarducci, Nicola Nante, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1060-1060
Open Access | Times Cited: 30
HPV-related diseases in male patients: an underestimated conundrum
Andrea Garolla, Andrea Graziani, Giuseppe Grande, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 2, pp. 261-274
Open Access | Times Cited: 25
HPV Infections—Classification, Pathogenesis, and Potential New Therapies
Beata Mlynarczyk-Bonikowska, Lidia Rudnicka
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7616-7616
Open Access | Times Cited: 13
Cervical cancer: Part I human papilloma virus vaccination in Taiwan
Szu‐Ting Yang, Peng‐Hui Wang, Hung‐Hsien Liu, et al.
Taiwanese Journal of Obstetrics and Gynecology (2024) Vol. 63, Iss. 3, pp. 320-328
Open Access | Times Cited: 12
Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 10
Current status and future directions for the development of human papillomavirus vaccines
Rui Wang, Hongpeng Huang, Chulin Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia
Ayichew Seyoum, Berhanu Seyoum, Tadesse Gure, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Vaccines for HPV-associated diseases
Jeffrey M. Skolnik, Matthew P. Morrow
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101224-101224
Closed Access | Times Cited: 21
Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis
Meenu Jain, Dhananjay Yadav, Urmila Jarouliya, et al.
Pathogens (2023) Vol. 12, Iss. 12, pp. 1380-1380
Open Access | Times Cited: 20
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial
Hitt Sharma, Sameer Parekh, Pramod Pujari, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 12, pp. 1321-1333
Closed Access | Times Cited: 18
Comparison of diagnostic accuracy and acceptability of self-sampling devices for human Papillomavirus detection: A systematic review
Gulzhanat Aimagambetova, Kuralay Atageldiyeva, Аizada Marat, et al.
Preventive Medicine Reports (2024) Vol. 38, pp. 102590-102590
Open Access | Times Cited: 7
Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
Xiaoxue Lang, Xiangtao Wang, Meihua Han, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4533-4568
Open Access | Times Cited: 7
The impact of internet health information seeking on COVID-19 vaccination behavior in China
Yunyun Zhang, Lidong Zhang, Hongyu Guan, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
An engineered Accum‐E7 protein‐based vaccine with dual anti‐cervical cancer activity
Jean‐Pierre Bikorimana, Jamilah Abusarah, Marina Gonçalves, et al.
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1102-1113
Open Access | Times Cited: 6
Parental willingness of HPV vaccination in Mainland China: A meta-analysis
Sensen Tan, Sumeng Wang, Xunwen Zou, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Empowering Women’s Health: Insights Into HPV Vaccination and the Prevention of Invasive Cervical Cancer
Sachin Rathod, Jyotsna Potdar, Aishwarya Gupta, et al.
Cureus (2023)
Open Access | Times Cited: 15
Análisis sistémico del programa de vacunación en Argentina
Malena Garros, A Rolando, Jesica Ponce, et al.
Deleted Journal (2023) Vol. 2, pp. 32-32
Open Access | Times Cited: 15
Perceptions, Attitudes, and Barriers to Human Papillomavirus Vaccination Among Residents in Saudi Arabia: A Cross-Sectional Study
Hind Mousa Faqeeh, Rahaf Saeed Alsulayyim, Kholoud A Assiri, et al.
Cureus (2024)
Open Access | Times Cited: 5
THE ROLE OF TRANSFORMING GROWTH FACTOR Β IN CERVICAL CARCINOGENESIS
Kleber Paiva Trugilo, Guilherme Cesar Martelossi Cebinelli, Eliza Pizarro Castilha, et al.
Cytokine & Growth Factor Reviews (2024)
Closed Access | Times Cited: 5
Utilizing geospatial artificial intelligence to map cancer disparities across health regions
Ahmed Fadiel, Kenneth D. Eichenbaum, Mohammad Ali Abbasi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Uncommon high distribution of HPV-16, HPV-54, and HPV-56 in female referred to a laboratory in Karaj, Iran: indications of a paradigm shift in HPV genotypes?
Arash Letafati, Saeed Motlaghzadeh, Omid Salahi Ardekani, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis
Glauciane Resende do Nascimento, Ana Carolina da Silva Santos, Nayara Nascimento Toledo Silva, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top